Articlenpj antimicrobials and resistance2025
A systematic review of antimicrobial resistance transmission inferences at the human-livestock interface in Africa.
Article in npj antimicrobials and resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Spatial distribution and determinants of antimicrobial resistance in livestock across pathogen types, animal species and antimicrobial classes.BMC veterinary research · 2026Article
- Antimicrobial Resistance: A Bibliometric Review of Patient Health, Mechanisms, and Therapeutic Strategies.Pathogens (Basel, Switzerland) · 2026Review
- Prevalence and patterns of antimicrobial resistance among wildlife populations in Africa: a systematic review.npj antimicrobials and resistance · 2026Article
- Characterization of Multidrug-ResistantAnimals : an open access journal from MDPI · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The transmission of antibiotic-resistant bacteria across multi-species networks is a contributor to the global challenge of antimicrobial resistance (AMR). AMR transmission inferencing, a retrospective process, is critical for refining the evidence underpinning current control strategies. In Africa, where AMR is associated with an estimated 1.05 million deaths annually, it is crucial to evaluate how AMR transmission inferences are made and to consider their implications for achieving national action plan goals. Key questions that need to be addressed in these settings include: (a) How is transmission defined? (b) How are transmission studies designed? (c) Which pathogens or commensal bacteria are used to infer AMR transmission? (d) How granular and reliable is the data used to make transmission inferences? (e) Can the frequency of transmission events be quantified? and (f) Can the directionality of transmission between hosts be established? In this systematic review, we examine the evidence informing current control strategies by analysing 34 studies from Africa, involving 18,604 human and livestock samples and 16 sentinel bacteria. Transmission inferences largely rely on cross-sectional studies with limited sample representativeness. Gram-negative bacteria, mainly Escherichia coli (64.71%), form the basis of most inferences. Most inferences remain qualitative, and analyses often overlook uncertainty quantification. In addition, studies are potentially underpowered as only 25% of collected samples are used for transmission inferencing. Based on this analysis, we propose a framework that leverages the growing use of genomic epidemiology to infer AMR transmission with an aim of supporting the design and evaluation of targeted interventions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.